Products
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$10/mo
Lower than 66% of peersNiche median $19/mo
Creators
Tom Qiu
No social account linked
Launched
2y ago
2024-10-24 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    All-in-one investment research platform, powered by AI

    Oct 24, 2024 · 2y agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2023-09-21

KeywordMonthly volume
stonkzz470
stonks siense430
stonks rising390
stonks down320
stonksup60

Traffic data: Vaneform

Pricing

Starter
$10/mo
6,000 credits / month · Connect up to 1 brokerage
Pro
$30/mo
30,000 credits / month (5x Starter) · Connect up to 3 brokerages
Max
$90/mo
120,000 credits / month (20x Starter) · Connect up to 10 brokerages

Trial: None · 3 paid tiers ($10–$90) · Observed 2026-11-04 · Source page

Entry price $10/mo, Lower than 66% of peers; “Financial Data & Research” median is $19/mo.View pricing benchmark

Website snapshots

Indexed 2024-10-24

Key pages

Desktop & mobile archive
Home
stonksup.io/ Snapshot 2026-11-04

Questions & evidence

How much does StonksUp cost?
Starter: $10/mo; Pro: $30/mo; Max: $90/mo. Observed 2026-11-04. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does StonksUp get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is StonksUp and what platforms does it support?
StonksUp is catalogued under Financial Data & Research: Invest with your own agents. Supported platforms: Mobile App.

Related products in this category

Finance / Financial Data & Research

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.